Unknown

Dataset Information

0

A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop).


ABSTRACT: In this study, we describe a novel thrombomodulin (TM) mutation (c.1611C>A) that codes for a change from cysteine 537 to a premature stop codon (p.Cys537Stop). Three members of a family with a history of posttraumatic bleeding were identified to be heterozygous for this TM mutation. All coagulation screening tests, coagulation factor assays, and platelet function test results were within normal limits. However, the endogenous thrombin potential was markedly reduced at low-tissue factor concentration, and failure to correct with normal plasma indicated the presence of a coagulation inhibitor. Plasma TM levels were highly elevated (433-845 ng/ml, normal range 2-8 ng/ml, equating to 5 to 10 nM), and the addition of exogenous protein C further decreased thrombin generation. The mutation, p.Cys537Stop, results in a truncation within the carboxyl-terminal transmembrane helix. We predict that as a consequence of the truncation, the variant TM is shed from the endothelial surface into the blood plasma. This would promote systemic protein C activation and early cessation of thrombin generation within a developing hemostatic clot, thereby explaining the phenotype of posttraumatic bleeding observed within this family.

SUBMITTER: Langdown J 

PROVIDER: S-EPMC4168350 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop).

Langdown Jonathan J   Luddington Roger J RJ   Huntington James A JA   Baglin Trevor P TP  

Blood 20140721 12


In this study, we describe a novel thrombomodulin (TM) mutation (c.1611C>A) that codes for a change from cysteine 537 to a premature stop codon (p.Cys537Stop). Three members of a family with a history of posttraumatic bleeding were identified to be heterozygous for this TM mutation. All coagulation screening tests, coagulation factor assays, and platelet function test results were within normal limits. However, the endogenous thrombin potential was markedly reduced at low-tissue factor concentra  ...[more]

Similar Datasets

| S-EPMC7694933 | biostudies-literature
| S-EPMC3500177 | biostudies-literature
| S-EPMC4342361 | biostudies-literature
| S-EPMC5240573 | biostudies-literature
| S-EPMC4653699 | biostudies-literature
| S-EPMC6201930 | biostudies-literature
| S-EPMC10104465 | biostudies-literature
2021-07-14 | GSE179970 | GEO
| S-EPMC3666459 | biostudies-literature
| S-EPMC4110339 | biostudies-literature